Fundamentals

Valuation

Metric	Q3	Q1	Δ in %
EV/EBITDA	188.54	31.80	11.02
Graham Fair Price	-32.90	28.88	43.05
PEG	-73.28	0.68	-2.56
Price/Book	-3.29	0.89	0.92
Price/Cash Flow	45.12	46.82	32.26
Prices/Earnings	135.08	26.94	11.46
Price/Sales	-6.76	6.19	6.64
Price/FCF	45.12	46.82	32.26
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q1	Δ in %
Gross Profit Margin	-8.26	0.92	1.00
Operating Margin	-59.66	0.08	0.19
ROA	-56.97	< 0.005	< 0.005
ROE	0.02	< 0.005	-58.86
ROIC	0.01	< 0.005	-52.69
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q1	Δ in %
Debt QOQ	-0.32	0.02	1283.79
Dividends QOQ	< 0.005	0.02	721.68
EBIT QOQ	-0.67	0.65	-3.26
EPS QOQ	-0.04	0.39	779.80
FCF QOQ	0.27	-0.67	148.10
Revenue QOQ	0.53	0.85	60.03
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	-10660.75	-100.00
Days Sales Outstanding (DSO)	171.15	157.06	-8.23
Inventory Turnover	0.00	< 0.005	-100.00
Debt/Capitalization	0.42	0.34	-20.44
Quick Ratio	5.82	0.82	-85.90
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q1	Δ in %
Book Value	64.11	67.06	4.61
Cash	152.91	143.99	-5.83
Capex	-0.16	-0.42	-161.90
Free Cash Flow	1.83	1.27	-30.28
Revenue	8.87	9.62	8.51
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q3	Q1	Δ in %
Current Ratio	2.40	0.37	-84.54
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-23.86	-48.84	-104.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating